Tuesday Bro Newsday! The “NEW” Harms of Vaping From JAHA – Also IQOS / Bloomberg

https://grimmgreen.com/2020/10/28/tuesday-bro-newsday-the-new-harms-of-vaping-from-jaha-also-iqos-bloomberg/

Welcome back to Tuesday Bro NEWSDAY. New name, new host, same reliable news and advocacy.

Each week for roughly a dangle-clack-free hour and a half Danielle and I will be discussing the topics of the day. As well as current breaking news from the world of vaping, nicotine and tobacco harm reduction.

Today’s topics include SCIENCE!! or… “junk” science rather from the AHA. They really REALLY want “EVALI” to be somehow related to nicotine vaping, and are willing to manufacture the science to get there. We will hopefully also discuss some IQOS news. Is it any safer than smoking? was that all a lie? well according to Bloomberg… yes.

All timestamps, links and podcast version of this stream will be down below

[TIMESTAMPS COURTESY OF JEREMY V] Vlog Starts at – 06:27 Getting to Know Danielle Jones – 08:36 CASAA Calls to Action – 23:14 Veritas Cohort Study – 26:49 You Don’t Know Nicotine Update – 27:54 Golden Oldies Capitol Tour – 30:21 New Vaping Dangers? – 33:32 Response from Clive Bates – 01:09:40 IQOS – 01:17:13

My TwitterDanielle’s Twitter

CASAA VAPE MAIL CALL TO ACTION
OREGON COLORADOMICHIGAN

You Don’t Know Nicotine World Wide Premiere

Golden Oldies Capitol Tour

Golden Oldies Twitter

E‐cigarette or Vaping Product Use–Associated Lung Injury Produced in an Animal Model From Electronic Cigarette Vapor Exposure Without Tetrahydrocannabinol or Vitamin E Oil – American Heart Association

Amelia Howard’s Thread on the non-vit-e-evali

Clive Bates Response

Expose Tobacco on twitter

The U.S. FDA Ruling on IQOS: Spin vs Truth

Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England

The Stanton Glantz BLOG ( but you don’t have to go there )

Podcast is also available on iTunes

-Grimm

https://grimmgreen.com/2020/10/28/tuesday-bro-newsday-the-new-harms-of-vaping-from-jaha-also-iqos-bloomberg/

Welcome back to Tuesday Bro NEWSDAY. New name, new host, same reliable news and advocacy.

Each week for roughly a dangle-clack-free hour and a half Danielle and I will be discussing the topics of the day. As well as current breaking news from the world of vaping, nicotine and tobacco harm reduction.

Today’s topics include SCIENCE!! or… “junk” science rather from the AHA. They really REALLY want “EVALI” to be somehow related to nicotine vaping, and are willing to manufacture the science to get there. We will hopefully also discuss some IQOS news. Is it any safer than smoking? was that all a lie? well according to Bloomberg… yes.

All timestamps, links and podcast version of this stream will be down below

[TIMESTAMPS COURTESY OF JEREMY V] Vlog Starts at – 06:27 Getting to Know Danielle Jones – 08:36 CASAA Calls to Action – 23:14 Veritas Cohort Study – 26:49 You Don’t Know Nicotine Update – 27:54 Golden Oldies Capitol Tour – 30:21 New Vaping Dangers? – 33:32 Response from Clive Bates – 01:09:40 IQOS – 01:17:13

My TwitterDanielle’s Twitter

CASAA VAPE MAIL CALL TO ACTION
OREGON COLORADOMICHIGAN

You Don’t Know Nicotine World Wide Premiere

Golden Oldies Capitol Tour

Golden Oldies Twitter

E‐cigarette or Vaping Product Use–Associated Lung Injury Produced in an Animal Model From Electronic Cigarette Vapor Exposure Without Tetrahydrocannabinol or Vitamin E Oil – American Heart Association

Amelia Howard’s Thread on the non-vit-e-evali

Clive Bates Response

Expose Tobacco on twitter

The U.S. FDA Ruling on IQOS: Spin vs Truth

Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England

The Stanton Glantz BLOG ( but you don’t have to go there )

Podcast is also available on iTunes

-Grimm

Cochrane Review: E-Cigarettes Appear More Effective Than Nicotine Replacement Therapy

https://vaping.org/cochrane-review-e-cigarettes-appear-more-effective-than-nicotine-replacement-therapy/

A newly published review in the Cochrane Library Database of Systematic Reviews provides further evidence that e-cigarettes and vapor products are more effective than nicotine replacement therapy (NRT) in helping smokers quit.

The authors employed 50 completed studies that had been published up to January 2020, which represented over 12,400 participants. Of the 50 studies, 26 were randomized control trials, “in which people who smoke were randomized to an [e-cigarette] or control condition.” In order to be included in the Cochrane review, “studies had to report abstinence from cigarettes at six months or longer and/or data on adverse events or other markers of safety at one week or longer.”

This is the latest Cochrane review update and includes 35 new studies. The authors found that there was “moderate-certainty evidence, limited by imprecision, that quit rates were higher in people randomized to nicotine [e-cigarettes] than in those randomized to nicotine replacement therapy.” The authors found that e-cigarette use translated “to an additional four successful quitters per 100.” The authors also found higher quit rates in participants that had used e-cigarettes containing nicotine, compared to the participants that had not used nicotine.

The authors noted the most reported adverse events were “throat/mouth irritation, headache, cough, and nausea, which tended to dissipate over time with continued use.”

The authors conclude that more “people probably stop smoking for at least six months using e-cigarettes than using nicotine replacement therapy,” and e-cigarettes may be useful to smokers without behavior support. Further, the authors found that for “every 100 people using nicotine e-cigarettes to stop smoking, 10 might successfully stop, compared with only six of 100 people using nicotine replacement therapy or nicotine-free e-cigarettes.”

The results are similar to a 2016 Cochrane review of e-cigarettes for smoking cessation, which found that there was “evidence from two trials that [e-cigarettes] help smokers to stop smoking in the long term compared to placebo [e-cigarettes].” Cochrane reviews are recognized worldwide as representing a gold standard for systematic reviews.

Regarding the new review, Prof Lion Shahab, Professor of Health Psychology and Co-Director of the UCL Tobacco and Alcohol Research Group, University College London, said “the authors also did not detect evidence of serious harms from electronic cigarettes, which should reassure policymakers and health bodies that electronic cigarettes have an important role to play in reducing the burden from combustible tobacco use.”

Peter Hajek, contributing senior author to the Cochrane review and Director of the Tobacco Dependence Research Unit at Queen Mary University of London remarked “e-cigarettes are a form of nicotine replacement that is more attractive to smokers and that seems more effective than the earlier products. The results of this new review of randomised trials of vaping tally with other evidence from cohort and epidemiological studies, suggesting that for many smokers, e-cigarettes represent an effective tool for quitting smoking.”

E-cigarettes and vaping tools have emerged as an effective tool in helping smokers quit. Despite this, many elected officials have moved to ban their sale in localities and states, with these officials often claiming that e-cigarettes are not needed because FDA-approved quitting tools exist. This study provides further evidence that e-cigarettes have helped many American adults quit smoking and are, indeed, more effective than FDA-approved nicotine replacement therapy in helping smokers quit.

The post Cochrane Review: E-Cigarettes Appear More Effective Than Nicotine Replacement Therapy appeared first on American Vaping Association.

https://vaping.org/cochrane-review-e-cigarettes-appear-more-effective-than-nicotine-replacement-therapy/

A newly published review in the Cochrane Library Database of Systematic Reviews provides further evidence that e-cigarettes and vapor products are more effective than nicotine replacement therapy (NRT) in helping smokers quit.

The authors employed 50 completed studies that had been published up to January 2020, which represented over 12,400 participants. Of the 50 studies, 26 were randomized control trials, “in which people who smoke were randomized to an [e-cigarette] or control condition.” In order to be included in the Cochrane review, “studies had to report abstinence from cigarettes at six months or longer and/or data on adverse events or other markers of safety at one week or longer.”

This is the latest Cochrane review update and includes 35 new studies. The authors found that there was “moderate-certainty evidence, limited by imprecision, that quit rates were higher in people randomized to nicotine [e-cigarettes] than in those randomized to nicotine replacement therapy.” The authors found that e-cigarette use translated “to an additional four successful quitters per 100.” The authors also found higher quit rates in participants that had used e-cigarettes containing nicotine, compared to the participants that had not used nicotine.

The authors noted the most reported adverse events were “throat/mouth irritation, headache, cough, and nausea, which tended to dissipate over time with continued use.”

The authors conclude that more “people probably stop smoking for at least six months using e-cigarettes than using nicotine replacement therapy,” and e-cigarettes may be useful to smokers without behavior support. Further, the authors found that for “every 100 people using nicotine e-cigarettes to stop smoking, 10 might successfully stop, compared with only six of 100 people using nicotine replacement therapy or nicotine-free e-cigarettes.”

The results are similar to a 2016 Cochrane review of e-cigarettes for smoking cessation, which found that there was “evidence from two trials that [e-cigarettes] help smokers to stop smoking in the long term compared to placebo [e-cigarettes].” Cochrane reviews are recognized worldwide as representing a gold standard for systematic reviews.

Regarding the new review, Prof Lion Shahab, Professor of Health Psychology and Co-Director of the UCL Tobacco and Alcohol Research Group, University College London, said “the authors also did not detect evidence of serious harms from electronic cigarettes, which should reassure policymakers and health bodies that electronic cigarettes have an important role to play in reducing the burden from combustible tobacco use.”

Peter Hajek, contributing senior author to the Cochrane review and Director of the Tobacco Dependence Research Unit at Queen Mary University of London remarked “e-cigarettes are a form of nicotine replacement that is more attractive to smokers and that seems more effective than the earlier products. The results of this new review of randomised trials of vaping tally with other evidence from cohort and epidemiological studies, suggesting that for many smokers, e-cigarettes represent an effective tool for quitting smoking.”

E-cigarettes and vaping tools have emerged as an effective tool in helping smokers quit. Despite this, many elected officials have moved to ban their sale in localities and states, with these officials often claiming that e-cigarettes are not needed because FDA-approved quitting tools exist. This study provides further evidence that e-cigarettes have helped many American adults quit smoking and are, indeed, more effective than FDA-approved nicotine replacement therapy in helping smokers quit.

The post Cochrane Review: E-Cigarettes Appear More Effective Than Nicotine Replacement Therapy appeared first on American Vaping Association.

Is it safe to manually set ohms?

https://www.reddit.com/r/Vaping/comments/jf56a9/is_it_safe_to_manually_set_ohms/

I have a Odin DNA75c and sometimes when I do a build on my kayfun lite 24mm clone the ohms are around .75 and it comes up as throttling when I try and fire.

If I manually lower the ohms to around .6 it works fine.

I'm using SS31L superfine clapton by vandyvape at like 6 wraps 2mm inner diameter in SS316L profile at 22 watts 190 degrees celcius with a preheat at 30 watts with about %80 punch.

I am using the gauges theme and have read conflicting information that this can cause issues with throttling.

Any advice would be great.

submitted by /u/Salmon66
[link] [comments]

https://www.reddit.com/r/Vaping/comments/jf56a9/is_it_safe_to_manually_set_ohms/

I have a Odin DNA75c and sometimes when I do a build on my kayfun lite 24mm clone the ohms are around .75 and it comes up as throttling when I try and fire.

If I manually lower the ohms to around .6 it works fine.

I'm using SS31L superfine clapton by vandyvape at like 6 wraps 2mm inner diameter in SS316L profile at 22 watts 190 degrees celcius with a preheat at 30 watts with about %80 punch.

I am using the gauges theme and have read conflicting information that this can cause issues with throttling.

Any advice would be great.

submitted by /u/Salmon66
[link] [comments]

What’s the difference between DotAio & DotAio SE??

https://www.reddit.com/r/Vaping/comments/jc999v/whats_the_difference_between_dotaio_dotaio_se/

I was planning to buy one of those but I'm getting confused about both of them What is the difference between them??

submitted by /u/XiongZaii
[link] [comments]

https://www.reddit.com/r/Vaping/comments/jc999v/whats_the_difference_between_dotaio_dotaio_se/

I was planning to buy one of those but I'm getting confused about both of them What is the difference between them??

submitted by /u/XiongZaii
[link] [comments]